Table 1.

Summary of motor function recovery at 20 weeks

	Group I	Group II	Group III	Group IV	Group V	p-value
Medication after allograft	autograft(control)	Cryopreserved allograft	Cold preserved allograft	Cryopreserved allograft + FK506 (0.1 mg/kg)	Cold preserved allograft + FK506 (0.1 mg/kg)
No. of animals tested	12	11	13	13	11
Animal weight
Initial weight (g)	341 ± 13.35	339 ± 26.4	327 ± 11.1	329 ± 17.6	338 ± 25.1	p = 0.132
Final weight (g)	521 ± 28.4	543 ± 29.1	537 ± 19.2	486 ± 25.1	488 ± 19.1	p = 0.011
Ankle angle
Maximum passive plantar flexion angle (°)	127 ± 13.0	128 ± 8.5	134 ± 12.7	138 ± 6.5	137 ± 9.8	p = 0.070
% of contralateral side	86.1 ± 8.67	87.2 ± 6.23	90.3 ± 5.91	96.5 ± 7.26	96.2 ± 5.32	p < 0.001
CMAP
Amplitude (mV)	16.0 ± 5.24	15.7 ± 5.51	18.9 ± 5.66	14.9 ± 4.08	18.9 ± 5.07	p = 0.064
% of contralateral side	63.3 ± 23.67	59.9 ± 17.75	55.3 ± 14.89	61.6 ± 17.75	61.0 ± 15.24	p = 0.082
MITF
Tibialis anterior muscle force (g)	691.9 ± 115.11	609.0 ± 64.57	719.0 ± 111.16	690.8 ± 111.16	682.0 ± 174.59	p = 0.020
% of contralateral side	60.9 ± 17.91	60.4 ± 16.68	60.2 ± 21.29	63.7 ± 19.21	67.1 ± 19.77	p = 0.148
Wet muscle weight
Tibialis anterior muscle force (g)	0.62 ± 0.063	0.62 ± 0.050	0.597 ± 0.058	0.66 ± 0.037	0.593 ± 0.064	p = 0.022
% of contralateral side	72.1 ± 6.13	72.5 ± 6.24	69.3 ± 6.53	80.5 ± 6.58	79.0 ± 8.75	p = 0.001